Showing results (1841-1850 of 2,351) with videos related to
Sort By:
Pageof 236
Allergy and Asthma Proceedings|May 13, 2021
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life studyAndriana I Papaioannou, Myrto Mplizou, Konstantinos Porpodis, et al.Allergy and Asthma Proceedings|May 13, 2021
Evaluation of anaphylaxis recurrence and adrenaline autoinjector use in childhoodIrem Turgay Yagmur, Ozge Yilmaz Topal, Ilknur Kulhas Celik, et al.Allergy and Asthma Proceedings|August 10, 2021
COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptanceJoseph A BellantiAllergy and Asthma Proceedings|June 17, 2020
An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trialDavid M Fleischer, Sharon Chinthrajah, Amy M Scurlock, et al.Allergy and Asthma Proceedings|December 18, 2004
Clinical efficacy, mechanisms of action, and adverse effects of complementary and alternative medicine therapies for asthmaLeonard Bielory, Jonathan Russin, Gary B ZuckermanAllergy and Asthma Proceedings|December 18, 2004
Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unitRobert B Berkowitz, Frank McCafferty, Cheryl Lutz, et al.Allergy and Asthma Proceedings|February 16, 2005
Triamcinolone acetonide and fluticasone propionate nasal sprays provide comparable relief of seasonal allergic rhinitis symptoms regardless of disease severityHarold B Kaiser, Yuning Liao, Phyllis Diener, et al.Allergy and Asthma Proceedings|February 16, 2005
Effect of the two different leukotriene receptor antagonists, montelukast and zafirlukast, on quality of life: a 12-week randomized studyGraziano Riccioni, R Della Vecchia, C Di Ilio, et al.Pageof 236